spironolactone has been researched along with oxadiazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| di Mario, C; Francis, DP; Hayward, C; Krum, H; Lyon, AR; Ozdemir, BA; Patel, HC; Rosen, SD | 1 |
| Birnkrant, DJ; Black, JB | 1 |
2 review(s) available for spironolactone and oxadiazoles
| Article | Year |
|---|---|
Magnitude of blood pressure reduction in the placebo arms of modern hypertension trials: implications for trials of renal denervation.
Topics: Amides; Antihypertensive Agents; Benzimidazoles; Benzopyrans; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Control Groups; Double-Blind Method; Drug Resistance; Eplerenone; Ethanolamines; Fumarates; Humans; Hypertension; Imidazoles; Kidney; Nebivolol; Oxadiazoles; Placebo Effect; Placebos; Randomized Controlled Trials as Topic; Regression Analysis; Research Design; Spironolactone; Sympathectomy; Tetrazoles; Treatment Outcome | 2015 |
Year in review 2019: Neuromuscular diseases.
Topics: Cardiomyopathies; Humans; Morpholinos; Muscular Dystrophy, Duchenne; Oxadiazoles; Spironolactone | 2020 |